Revision Rate and Patient-Reported Outcome After Hip Resurfacing Arthroplasty: A Concise Follow-Up of 1064 Cases

Börnert, Sonja; Lützner, Jörg; Beyer, Franziska; Günther, Klaus‐Peter; Hartmann, A.

doi:10.1016/j.arth.2015.06.041

Cited by 12 publications

(17 citation statements)

References 32 publications

(42 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…This finding is Cobalt ( , which identified female sex as an independent predictor of lower survival [3]. Our study, however, accounts for a more robust set of confounding variables including metal ion levels and multiple PROMs.…”

Section: Discussionmentioning

confidence: 82%

“…We also were unable to assess the associations between other possible confounding variables and revision, such as BMI, as it was not collected for all patients in the study, and dysplasia, as none of the 27 dysplastic hips in our study were revised. However, other studies in similar patient populations have not identified a relationship between BMI and revision incidence [3,14].…”

Section: Discussionmentioning

confidence: 99%

“…Female sex has been identified as a risk factor for revision surgery in hip resurfacing arthroplasty and has been associated with more complications, yet studies have failed to account for confounding variables and have analyzed multiple implants in the same cohort [3,5,8,14]. As the ASR TM implant has been known to have a higher incidence of revision and increased prevalence of adverse local tissue reaction compared with other MoM hip resurfacing arthroplasty devices, we thought it was important to assess this implant.…”

Section: Discussionmentioning

confidence: 99%

“…Sex and/or gender has been identified as an independent risk factor for patients undergoing revision surgery [3,8,11,14]. In a study examining 1419 arthroplasties using MoM prostheses, performed at one center, following four different devices, only female sex and young age were independent predictors for the risk of revision [8].…”

Section: Discussionmentioning

confidence: 99%

“…Some studies have indicated that females receiving hip resurfacing arthroplasties with MoM prostheses are at an especially high risk of revision surgery and report higher levels of pain compared with males [3,14]. A systematic review from 2015 exploring the effect of sex on complications after hip resurfacing arthroplasties found that female patients were at greater risk of adverse local tissue reaction, dislocation, aseptic loosening, and revision surgery [11].…”

Section: Introductionmentioning

confidence: 99%

See 4 more Smart Citations

Are Females at Greater Risk for Revision Surgery After Hip Resurfacing Arthroplasty With the Articular Surface Replacement Prosthesis?

Donahue

Lindgren

Galea

et al. 2016

Clinical Orthopaedics &Amp; Related Research

View full text Add to dashboard Cite

Background Female patients undergoing hip resurfacing arthroplasties may be at greater risk of revision surgery than males, but it is unclear whether this is related to sex or other factors. We focused our analysis on data from a prospective multicenter cohort study monitoring the ASR TM hip resurfacing arthroplasty prosthesis on the potential association of sex on patient-reported outcome measures (PROMs), metal ion levels, revision surgery, and presence of adverse local tissue reaction. As thousands of patients with the ASR TM prosthesis are still undergoing followup it is critical to optimize the protocol for monitoring these patients.Questions/purposes We wished (1) to assess the associations between sex and implant survival, and adverse local tissue reaction; and (2) to report the differences between sexes in metal ion levels and patient-reported outcome measures. Methods One thousand two hundred fifty-two patients (1390 hips) who underwent hip resurfacing arthroplasty with implantation of the ASR TM prosthesis from April 2003 to July 2010 were eligible for enrollment in a multicenter followup study of the ASR TM Hip Resurfacing System after the voluntary recall of this device was initiated by DePuy in 2010. Nine hundred seventy patients (1098 hips) were enrolled at a mean of 7 years after surgery, with a mean followup of 2 years (range, 1-3.5 years). One of the authors (OM), or a member of his immediate family, has or may receive payments or benefits, during the study period, an amount of USD 10,000 to USD 100,000, from Zimmer Inc, Biomet, Corin (Cirencester, UK), Iconacy (Warsaw, IN, USA), Renovis (Redlands, CA, USA), Conformis (Burlington, MA, USA), Aston Medical (Saint-É tienne, France), Meril Healthcare (Vapi, Gujarat, India), Arthex (Naples, FL, USA), Mako Surgical Corp, Cambridge Polymer Group (Boston, MA, USA), and Orthopedic Technology Group (Boston, MA, USA). One of the authors (HM), or a member of his immediate family, has or may receive payments or benefits, during the study period, an amount of USD 10,000 to USD 100,000, from Zimmer Inc, Biomet, Corin, and RSA Biomedical (Umeå, Sweden Nine hundred fifty-eight patients (1084 hips) met the inclusion criteria: ability to provide informed consent, complete PROMs, and continued routine followup. A subset of patients (150 patients, 171 hips), who all were from one center, with annual metal artifact reduction sequence MRI were analyzed. Ninety-three percent of patients from this center had routine MRI performed. The EuroQoL (EQ-5D), Harris hip score (HHS), University of California Los Angeles (UCLA) activity score, VAS pain, radiographs, patient and surgery details, and blood cobalt and chromium levels were obtained. Cox regression analysis was conducted to identify factors associated with implant survival, using any revision as the end point, and presence of adverse local tissue reaction. Results In patients who had unilateral surgery, the only variable found to be associated with revision surgery was HHS (hazard ratio [HR], 0.96; 95% CI, 0.9...

show abstract

Section: Discussionmentioning

confidence: 82%

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

Are Females at Greater Risk for Revision Surgery After Hip Resurfacing Arthroplasty With the Articular Surface Replacement Prosthesis?

Donahue

Lindgren

Galea

et al. 2016

Clinical Orthopaedics &Amp; Related Research

View full text Add to dashboard Cite

show abstract

Current indications for hip resurfacing arthroplasty in 2016

Sershon

Balkissoon

Valle

2016

Curr Rev Musculoskelet Med

View full text Add to dashboard Cite

Hip resurfacing arthroplasty (HRA) is an alternative to conventional, stemmed total hip arthroplasty (THA). The best reported results are young, active patients with good bone stock and a diagnosis of osteoarthritis. Since the 1990s, metal-on-metal (MoM) HRA has achieved excellent outcomes when used in the appropriate patient population. Concerns regarding the metal-on-metal bearing surface including adverse local tissue reaction (ALTR) to metal debris have recently lead to a decline in the use of this construct. The current paper aims to provide an updated review on HRA, including a critical review of the most recent literature on HRA.

show abstract